# Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation

> **NCT02654561** · PHASE3 · UNKNOWN · sponsor: **China Medical University, China** · enrollment: 600 (estimated)

## Conditions studied

- Sepsis
- Disseminated Intravascular Coagulation

## Interventions

- **DRUG:** Heparin Sodium
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02654561
- **Lead sponsor:** China Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-12
- **Primary completion:** 2024-12
- **Final completion:** 2025-06
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2023-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02654561

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02654561, "Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02654561. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*